C.L. Aquilante - Concepedia

Concepedia

Author

C.L. Aquilante

University of Colorado Denver

Also Known As

C A Aquilante, C Aquilante, C L Aquilante, C.L. Aquilante, CL Aquilante

16

Publications

1.1K

Citations

4

H-Index

10

Concepts

All Affiliations

University of Colorado Denver University of Florida

CA

About

C.L. Aquilante is an author at University of Colorado Denver specializing in pharmacotherapy, pharmacogenomics, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	97
2	Pharmacology	2	2	97
3	Drug Discovery	2	2	97
4	Pharmacogenomics	2	2	97
5	Drug Resistance	1	1	47

C.L. Aquilante

×

4

Publications

1.1K

Citations

4

H-Index

	Year	Citations
Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of Warfarin Charles Eby, JA Johnson, Elena Deych, Clinical Pharmacology & Therapeutics	2008	829
The Effect of Lopinavir/Ritonavir on the Renal Clearance of Tenofovir in HIV-infected Patients Kiser Jj, ML Carten, C.L. Aquilante, Clinical Pharmacology & Therapeutics	2007	204
Sequencing drug response with HapMap Matthew J. Lin, C.L. Aquilante, Julie A. Johnson, The Pharmacogenomics Journal MedicineDrug ResponseOmicsPharmacogenomicsPharmacotherapy	2005	50
Availability of pharmacogenomics-based prescribing information in drug package inserts for currently approved drugs Issam Zineh, Tobias Gerhard, C.L. Aquilante, The Pharmacogenomics Journal Drug SafetyMedicineDrug DiscoveryDrug Information SystemDrug Package Inserts	2004	47

Page 1